Clinical Trials List
2021-09-02 - 2026-05-25
Phase III
Recruiting6
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 王元欽 Division of Hematology & Oncology
- 陳建誠 無
- Ming-Chung Kao Division of Hematology & Oncology
- Hung Chang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ta-Chih Liu Division of Hematology & Oncology
- 吳敬炫 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tzu-Ting Chen 無
- Wei-Ching Lin 無
- Ching-Chan Lin 無
- Chi-Ching Chen 無
- 王秀慈 無
- Ming-Yu Lien 無
- Ming-Hung Tsai 無
- Yu-Min Liao 無
- Che-Hung Lin 無
- 鄭富銘 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yi-Chang Liu Division of Hematology & Oncology
- Tsung-Jang Yeh Division of Hematology & Oncology
- Hui-Ching Wang Division of Hematology & Oncology
- 柯亞倫 Division of Hematology & Oncology
- Shih-Feng Cho Division of Hematology & Oncology
- 高育青 Division of Hematology & Oncology
- Jeng-Shiun Du Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ta-Chih Liu Division of Hematology & Oncology
- 吳敬炫 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
320 participants
